Doctor profile · Federal record
Dr. Brad Kahl, MD
Medical Oncology Physician (CMS: Medical Oncology) · Saint Louis, MO
- NPI 1407822430
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4921 Parkview Pl, Div Im Medical Oncology, Ste 7A, 7B, 7C
Saint Louis, MO 631101032
(800) 647-2098
fax (314) 362-3192 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- April 17, 2025
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Missouri #2015029481
- Medicaid
- MO #200025326
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407822430. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
17,492
Distinct HCPCS
10
Medicare allowed
$607,781
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 5,600 | 11 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 3,600 | 15 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 2,400 | 16 | $24 | |
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,650 | 15 | $48 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,030 | 55 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 460 | 32 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 305 | 126 | $125 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 305 | 47 | $78 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 260 | 15 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 258 | 114 | $8 |
In context: peer comparison
Among 44 peers in Saint Louis Medical Oncology Physician, average services per provider: 919. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$51,960
Transactions
33
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Adc Therapeutics America, INC. | 8 | $10,444.62 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $6,165.00 | |
| Pfizer INC. | 1 | $5,220.00 | |
| Genentech USA, INC. | 2 | $5,130.00 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $3,460.00 | |
| GlaxoSmithKline, LLC. | 1 | $3,300.00 | |
| F. Hoffmann-la Roche Ag | 4 | $3,273.50 | |
| Abbvie INC. | 5 | $3,218.82 | |
| Merck Sharp & Dohme LLC | 1 | $3,050.00 | |
| BeiGene USA, INC. | 2 | $2,937.50 | |
| Eli Lilly and Company | 1 | $2,475.00 | |
| AstraZeneca Uk Limited | 1 | $1,370.00 | |
| Acrotech Biopharma INC. | 1 | $1,350.00 | |
| Genentech, INC. | 1 | $550.00 | |
| Gilead Sciences, INC. | 1 | $15.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
572
Patients
147
Total drug cost
$2,370,557
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 130 | 36 | $2,578 |
| Brukinsa (Zanubrutinib) | Brand | 94 | 20 | $1,284,691 |
| Prochlorperazine Maleate | Generic | 50 | 36 | $1,279 |
| Prednisone | Generic | 46 | 18 | $166 |
| Venclexta (Venetoclax) | Brand | 38 | 11 | $536,444 |
| Gabapentin | Generic | 34 | 0 | $988 |
| Calquence (Acalabrutinib Maleate) | Brand | 33 | 0 | $523,410 |
| Famotidine | Generic | 25 | 0 | $389 |
| Levothyroxine Sodium | Generic | 22 | 0 | $230 |
| Eliquis (Apixaban) | Brand | 21 | 0 | $16,082 |
Hospital affiliations
Frequently asked questions
What is Dr. Brad Kahl's medical specialty?
Dr. Brad Kahl practices Medical Oncology Physician in Saint Louis, MO.
Where does Dr. Brad Kahl practice?
Dr. Brad Kahl practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 8006472098.
What is Dr. Brad Kahl's NPI?
Dr. Brad Kahl's National Provider Identifier (NPI) is 1407822430, issued by NPPES.
Does Dr. Brad Kahl accept Medicare assignment?
Yes. Dr. Brad Kahl accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brad Kahl commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.